SkinBioTherapeutics PLC (SBTX) — Cash Flow Quality Index

Latest as of June 2025: -1.46x

SkinBioTherapeutics PLC (SBTX) has a Cash Flow Quality Index of -1.46x as of June 2025. Operating cash flow of GBX-494.84K is below net income of GBX337.85K, suggesting accrual-heavy earnings not yet converted to cash. Explore SkinBioTherapeutics PLC (SBTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.46x

Operating CF / Net Income

Operating Cash Flow

GBX-494.84K

GBX

Net Income

GBX337.85K

GBX

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for SkinBioTherapeutics PLC (None–None)

Year-by-year earnings quality comparison for SkinBioTherapeutics PLC.

Year	Quality Index	Operating CF (GBX)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.